Endo International's Total Assets for the quarter that ended in Dec. 2023 was $5,137 Mil.
During the past 12 months, Endo International's average Total Assets Growth Rate was -8.00% per year.
During the past 3 years, the average Total Assets Growth Rate was -18.50% per year.
During the past 5 years, the average Total Assets Growth Rate was -14.00% per year.
During the past 10 years, the average Total Assets Growth Rate was -7.90% per year.
During the past 13 years, Endo International's highest 3-Year average Total Assets Growth Rate was 81.60%. The lowest was -22.20%. And the median was 14.10%.
Total Assets is connected with ROA %. Endo International's annualizedROA % for the quarter that ended in Dec. 2023 was -187.93%. Total Assets is also linked to Revenue through Asset Turnover. Endo International's Asset Turnover for the quarter that ended in Dec. 2023 was 0.10.
Endo International Total Assets Historical Data
The historical data trend for Endo International's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
Endo International's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Endo International (OTCPK:ENDPQ) Total Assets Explanation
Note:
The Net Income data used here is four times the quarterly (Dec. 2023) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Endo International's Asset Turnover for the quarter that ended in Dec. 2023 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Endo International Total Assets Related Terms
Thank you for viewing the detailed overview of Endo International's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Endo International (Endo International) Business Description
Endo International PLC is a specialty pharmaceutical company with a considerable presence in pain management, urology, orthopedics, endocrinology, bariatrics, and others. It operates in four segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals, and International Pharmaceuticals. The company generates maximum revenue from the Branded Pharmaceuticals segment. Some of its products include XIAFLEX, SUPPRELIN, PERCOCET, TESTOPEL, VASOSTRICT, ADRENALIN, and APLISOL.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ENDPQ has been successfully added to your 